Cash & Short-Term Investments

$95.33M

Quarterly · Period ending: Jun 30, 2026 · USD

RIGL Cash & Short-Term Investments

Latest reported$95.33Mperiod endingJun 30, 2026

RIGL Quarterly Cash & Short-Term Investments ($52.99M → $95.33M)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

RIGL cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Jun 30, 2026	95,329,000
Mar 31, 2026	146,684,000
Dec 31, 2025	154,955,000
Sep 30, 2025	137,143,000
Jun 30, 2025	108,379,000
Mar 31, 2025	77,099,000
Dec 31, 2024	77,321,000
Sep 30, 2024	61,114,000
Jun 30, 2024	49,102,000
Mar 31, 2024	49,550,000
Dec 31, 2023	56,933,000
Sep 30, 2023	62,351,000
Jun 30, 2023	64,357,000
Mar 31, 2023	58,662,000
Dec 31, 2022	58,206,000
Sep 30, 2022	81,642,000
Jun 30, 2022	89,166,000
Mar 31, 2022	107,519,000
Dec 31, 2021	124,967,000
Sep 30, 2021	143,146,000
Jun 30, 2021	153,387,000
Mar 31, 2021	39,345,000
Dec 31, 2020	57,327,000
Sep 30, 2020	72,812,000
Jun 30, 2020	92,497,000
Mar 31, 2020	95,926,000
Dec 31, 2019	98,078,000
Sep 30, 2019	107,480,000
Jun 30, 2019	112,377,000
Mar 31, 2019	127,923,000
Dec 31, 2018	128,537,000
Sep 30, 2018	115,637,000
Jun 30, 2018	134,992,000
Mar 31, 2018	94,300,000
Dec 31, 2017	115,751,000
Sep 30, 2017	68,076,000
Jun 30, 2017	82,302,000
Mar 31, 2017	98,141,000
Dec 31, 2016	74,766,000
Sep 30, 2016	85,255,000
Jun 30, 2016	94,940,000
Mar 31, 2016	103,632,000
Dec 31, 2015	126,276,000
Sep 30, 2015	134,350,000
Jun 30, 2015	143,942,000
Mar 31, 2015	161,155,000
Dec 31, 2014	143,159,000
Sep 30, 2014	157,672,000
Jun 30, 2014	176,030,000
Mar 31, 2014	195,384,000
Dec 31, 2013	211,975,000
Sep 30, 2013	230,882,000
Jun 30, 2013	251,641,000
Mar 31, 2013	272,450,000
Dec 31, 2012	298,241,000
Sep 30, 2012	183,895,000
Jun 30, 2012	202,639,000
Mar 31, 2012	223,300,000
Dec 31, 2011	247,640,000
Sep 30, 2011	265,682,000
Jun 30, 2011	279,097,000
Mar 31, 2011	155,546,000
Dec 31, 2010	177,295,000
Sep 30, 2010	167,535,000
Jun 30, 2010	187,458,000
Mar 31, 2010	109,549,000
Dec 31, 2009	133,318,000
Sep 30, 2009	156,078,000
Jun 30, 2009	79,945,000
Mar 31, 2009	104,811,000
Dec 31, 2008	134,477,000
Sep 30, 2008	160,358,000
Jun 30, 2008	185,001,000
Mar 31, 2008	209,670,000
Dec 31, 2007	108,296,000
Sep 30, 2007	112,500,000
Jun 30, 2007	126,451,000
Mar 31, 2007	88,599,000
Dec 31, 2006	104,471,000
Sep 30, 2006	115,012,000
Jun 30, 2006	122,240,000
Mar 31, 2006	128,367,000
Dec 31, 2005	138,196,000
Sep 30, 2005	127,923,000
Jun 30, 2005	60,092,000
Mar 31, 2005	70,515,000
Dec 31, 2004	71,427,000
Sep 30, 2004	71,600,000
Jun 30, 2004	82,345,000
Mar 31, 2004	93,811,000
Dec 31, 2003	46,500,000
Sep 30, 2003	56,853,000
Jun 30, 2003	58,092,000
Mar 31, 2003	22,184,000
Dec 31, 2002	27,291,000
Sep 30, 2002	36,518,000
Jun 30, 2002	45,651,000
Mar 31, 2002	57,535,000
Dec 31, 2001	33,415,000
Sep 30, 2001	37,331,000